MRVI
$7.20+3.00%
Maravai LifeSciences Holdings Inc.Stock · HealthcareRussell 2000 · 0.02% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.0010% of IWV
MRVI financial statements
The full income statement, balance sheet, and cash-flow statement for Maravai LifeSciences Holdings Inc. (MRVI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 135.8M2024-09 141.6M2024-12 252.7M2025-03 254.6M2025-06 255.3M2025-09 144.7M2025-12 256.0M2026-03 258.2M2026-06 259.6M+91.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 186M-28.3% | 259M-10.3% | 289M-67.3% | 883M+10.5% | 799M+181.3% | |
| 34.0M-68.6% | 108M-22.7% | 140M | — | — | ||
| Cost of revenue | 152M+0.6% | 151M+1.4% | 149M-12.0% | 169M+20.2% | 141M+76.5% | |
| Research & development | 17.4M-9.5% | 19.2M+11.2% | 17.3M-5.9% | 18.4M+20.7% | 15.2M+63.6% | |
| Selling, general & administrative | 145M-10.3% | 162M+6.9% | 151M+17.1% | 129M+29.2% | 100M+6.2% | |
| Restructuring | 17.8M+1568.5% | -1.21M-118.8% | 6.47M | 0.00 | 0.00 | |
| Amortization of intangibles | 28.0M+1.5% | 27.5M+0.6% | 27.4M+12.7% | 24.3M+32.3% | 18.3M-9.7% | |
| Operating income | -215M+8.6% | -236M-644.5% | -31.6M-105.5% | 574M+3.5% | 555M+362.6% | |
| Interest expense | 27.0M-43.4% | 47.7M+3.9% | 45.9M+124.8% | 20.4M-32.5% | 30.3M-1.6% | |
| Interest & investment income | 11.4M-58.3% | 27.4M-1.2% | 27.7M+1085.9% | 2.34M | 0.00 | |
| Other non-operating income | -4.15M-77.4% | -2.34M-75.1% | -1.34M-273.5% | -358K-228.3% | 279K+121.4% | |
| Pre-tax income | -235M+10.1% | -261M-142.3% | 618M+12.0% | 551M+3.9% | 531M+549.7% | |
| Income tax | -4.21M-126.5% | -1.86M-100.2% | 756M+1143.4% | 60.8M-1.1% | 61.5M+2035.9% | |
| -131M+9.7% | -145M-21.7% | -119M-154.1% | 220M+21.0% | 182M+104.6% | ||
| Net income to non-controlling interest | -100.0M+12.9% | -115M-493.3% | -19.3M-107.2% | 270M-5.8% | 287M+2928.0% | |
| Preferred dividends | — | — | — | 0.00 | 0.00-100.0% | |
| Net income to common | -131M+9.7% | -145M-21.7% | -119M-154.1% | 220M+21.0% | 182M+136.8% | |
| -$0.90+14.3% | -$1.05-16.7% | -$0.90-153.9% | $1.67+7.1% | $1.56-33.9% | ||
| EPS (basic) | -$0.90+14.3% | -$1.05-16.7% | -$0.90-153.9% | $1.67+5.0% | $1.59-78.6% | |
| Weighted-avg shares (basic) | 144M+4.7% | 138M+4.5% | 132M+0.3% | 132M+14.6% | 115M+1009.0% | |
| Weighted-avg shares (diluted) | 144M+4.7% | 138M+4.5% | 132M-48.3% | 255M-1.0% | 258M+791.8% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 296M-31.0% | 429M-38.7% | 700M-17.5% | 848M+14.6% | 740M+123.2% | ||
| Cash & equivalents | 217M-32.7% | 322M-43.9% | 575M-9.0% | 632M+14.7% | 551M+133.4% | |
| Accounts receivable | 25.5M-33.8% | 38.5M-29.5% | 54.6M-60.6% | 139M+18.0% | 118M+130.3% | |
| Inventory | 40.5M-19.1% | 50.1M-2.6% | 51.4M+19.1% | 43.2M-16.3% | 51.6M+54.8% | |
| Prepaid expenses | 13.4M-26.3% | 18.1M-4.2% | 18.9M-26.6% | 25.8M+31.0% | 19.7M+77.5% | |
| 771M-23.6% | 1.01B-32.2% | 1.49B-34.8% | 2.28B+19.0% | 1.92B+51.0% | ||
| Property, plant & equipment | 151M-7.9% | 164M+1.0% | 163M+209.1% | 52.7M+13.7% | 46.3M-54.3% | |
| Operating lease right-of-use | 39.3M-25.3% | 52.6M-12.0% | 59.7M-6.5% | 63.9M+30.1% | 49.1M | |
| Goodwill | 129M-19.0% | 160M-51.0% | 326M+14.9% | 284M+85.7% | 153M-31.9% | |
| Intangible assets | 152M-22.3% | 195M-11.8% | 221M+2.0% | 217M+84.3% | 118M-33.8% | |
| Deferred tax assets | — | — | 0.00-100.0% | 766M-5.2% | 808M+87.2% | |
| Other non-current assets | 41.9M-30.0% | 59.8M-23.0% | 77.6M-32.8% | 116M+116.3% | 53.5M+1185.5% | |
| 44.9M-21.2% | 57.0M-34.9% | 87.5M-20.6% | 110M+17.5% | 93.8M-28.3% | ||
| Accounts payable | 2.91M-75.7% | 12.0M | — | 5.99M-26.5% | 8.15M-0.2% | |
| Accrued liabilities | 36.6M-7.6% | 39.6M-34.3% | 60.2M+12.9% | 53.4M+54.4% | 34.6M-10.3% | |
| Deferred revenue | 1.99M-16.4% | 2.38M-29.3% | 3.36M+8.8% | 3.09M-69.8% | 10.2M-86.9% | |
| Short-term & current debt | 5.44M+0.0% | 5.44M+0.0% | 5.44M+0.0% | 5.44M-9.3% | 6.00M+0.0% | |
| Current lease liability | 7.79M+4.2% | 7.48M+10.3% | 6.78M+8.2% | 6.27M+68.4% | 3.72M | |
| Finance lease liability (current) | 966K+22.0% | 792K+25.1% | 633K | 0.00 | — | |
| 398M-7.7% | 431M-38.2% | 698M-49.3% | 1.38B+0.3% | 1.37B+23.0% | ||
| Long-term debt | 286M-1.4% | 290M-44.0% | 519M-0.6% | 522M-0.5% | 525M-0.8% | |
| Non-current lease liability | 34.0M-17.8% | 41.4M-12.9% | 47.5M-7.8% | 51.6M+26.0% | 40.9M | |
| Operating lease liability (total) | 41.8M-14.4% | 48.9M-10.0% | 54.3M-6.1% | 57.8M+29.6% | 44.6M | |
| Finance lease liability (total) | 31.1M-2.5% | 31.9M-1.9% | 32.5M | — | — | |
| Finance lease liability | 30.1M-3.1% | 31.1M-2.5% | 31.9M | 0.00 | — | |
| Deferred tax liabilities | — | 11.0M | — | 0.00 | 0.00-100.0% | |
| Other non-current liabilities | 36.5M-30.5% | 52.5M-11.8% | 59.5M-13.7% | 69.0M+68.0% | 41.1M+1740.7% | |
| 212M-34.7% | 325M-21.9% | 417M-23.6% | 545M+72.8% | 315M+256.5% | ||
| Additional paid-in capital | 199M+9.5% | 182M+41.5% | 129M-6.8% | 138M+7.4% | 128M+50.8% | |
| Retained earnings | 10.1M-92.8% | 141M-50.7% | 286M-29.4% | 405M+119.3% | 185M+21511.4% | |
| Accumulated other comprehensive income | 524K | 0.00 | — | — | 0.00+100.0% | |
| Non-controlling interest | 160M-36.4% | 252M-32.5% | 373M+3.6% | 360M+56.6% | 230M+247.0% | |
| Total equity incl. non-controlling | 373M-35.4% | 577M-26.9% | 790M-12.7% | 905M+66.0% | 545M+252.4% | |
| Total liabilities & equity | 771M-23.6% | 1.01B-32.2% | 1.49B-34.8% | 2.28B+19.0% | 1.92B+51.0% | |
| Common shares outstanding | 256M+1.3% | 253M+0.5% | 251M-1.6% | 255M | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -57.6M-871.2% | 7.46M-94.1% | 126M-76.4% | 536M+45.4% | 369M+142.2% | ||
| Depreciation & amortization | 51.5M+6.5% | 48.4M+20.2% | 40.3M+26.4% | 31.8M+28.6% | 24.8M-4.5% | |
| Intangible amortization | 28.0M+1.5% | 27.5M+0.6% | 27.4M+12.7% | 24.3M+32.3% | 18.3M-9.7% | |
| Share-based compensation | 30.2M-38.9% | 49.4M+42.9% | 34.6M+85.3% | 18.7M+78.5% | 10.5M-57.5% | |
| Deferred income taxes | -20.0K-281.8% | 11.0K-100.0% | 755M+1684.0% | 42.3M-9.8% | 46.9M+958.4% | |
| Change in receivables | -12.8M+10.7% | -14.4M+83.0% | -84.4M-478.9% | 22.3M-68.4% | 70.4M+112.4% | |
| Change in inventory | -8.00M-2021.8% | -377K+41.9% | -649K+93.1% | -9.46M-143.8% | 21.6M+13.0% | |
| Change in payables | -7.35M-1116.2% | 723K-86.3% | 5.28M+434.9% | -1.58M-333.4% | 676K-42.5% | |
| -31.4M-29.2% | -24.3M+80.1% | -122M+54.3% | -268M-353.3% | 106M+1641.2% | ||
| Capital expenditure | 13.1M-55.7% | 29.7M-54.8% | 65.6M+283.6% | 17.1M+15.1% | 14.8M-41.6% | |
| Free cash flow | -70.7M-218.7% | -22.2M-136.6% | 60.7M-88.3% | 519M+46.7% | 354M+179.0% | |
| Acquisitions | 19.0M | 0.00-100.0% | 69.6M-70.9% | 239M | 0.00 | |
| Other investing activities | 0.00-100.0% | 1.80M | 0.00 | — | — | |
| -16.5M+93.0% | -236M-285.8% | -61.1M+67.4% | -187M-17.9% | -159M-398.9% | ||
| Long-term debt issued | 0.00-100.0% | 953K | 0.00-100.0% | 8.46M | 0.00-100.0% | |
| Long-term debt repaid | 5.44M-97.7% | 234M+4208.7% | 5.44M-60.8% | 13.9M+131.6% | 6.00M-98.5% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -5.64M-220.3% | -1.76M-400.6% | -352K | — | — | |
| FX effect on cash | -32.0K | 0.00 | 0.00 | 0.00+100.0% | -88.0K-617.6% | |
| Net change in cash | -106M+58.2% | -253M-341.7% | -57.2M-170.7% | 80.9M-74.3% | 315M+49.0% | |
| Interest paid | 25.0M-51.0% | 51.0M+15.2% | 44.3M+119.1% | 20.2M-25.8% | 27.2M-5.8% | |
| Income taxes paid | -555K-182.8% | 670K+122.4% | -2.99M-113.0% | 23.0M+2.5% | 22.5M+348.9% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 832M-39.6% | 1.38B+59.3% | 864M-54.1% | 1.88B-82.6% | 10.8B+1232.2% | |
| P/E | — | — | 35.2×+345.2% | 7.9×-86.7% | 59.3×+551.1% | |
| P/S | 4.5×-15.7% | 5.3×+157.9% | 2.1×-0.9% | 2.1×-84.6% | 13.5×+373.5% | |
| P/B | 3.9×-7.5% | 4.2×+154.4% | 1.7×-55.5% | 3.7×-89.1% | 34.2×+273.7% | |
| P/FCF | — | — | 5.3×+34.9% | 3.9×-87.1% | 30.5×+377.5% | |
| Earnings yield | — | — | 2.8%-77.5% | 12.7%+650.9% | 1.7%-84.6% | |
| FCF yield | — | — | 18.8%-25.9% | 25.4%+676.2% | 3.3%-79.1% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: MRVI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MRVI filings on SEC EDGAR → Not investment advice.